Incidence of and mortality from breast cancer since introduction of screening

BMJ

Volumn 312, Issue 7031, 1996, Pages 639-640

  Brewster, David ^a   Everington, Dawn ^a   Harkness, Elaine ^a   Gould, Ann ^a   Warner, Jan ^a   Dewar, John A ^a   Arrundale, Jack ^a  

^a HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LETTER; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; SCOTLAND;

EID: 0029996321     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7031.639b     Document Type: Letter

References (2)

1. Quinn M, Allen E on behalf of the United Kingdom Association of Cancer Registries. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 1995; 311: 1391–5. (25 November.)
2. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J, eds. Survival of cancer patients in Europe; the Eurocare study. Lyons: International Agency for Research on Cancer, 1995. (IARC scientific publications No 132.)